Hypertension : Comment augmenter le nombre de ses clients ?
HYVET : (The treatment of Hypertension in Patients 80 Years of Age or Older), Nigel S. et al. HYVET : Blood pressure control in the Hypertension in the Very Elderly Trial. ARA et CANCER : Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. The Acute Infarction Ramipril Efficacy Study Investigators. AIRE : (The Acute Infarction Ramipril Efficacy) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. IRMA-II : The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. Laffel : The beneficial effect of angiotensin-converting enzyme inhibitionwith captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. ALLHAT 2002 : (The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. ALLHAT 2000: (The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone.
Hypertension : Quelles sont les étapes de la prospection commerciale ?
IDNT : (The Irbesartan in Diabetic Nephropathy Trial) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. CAPPP : (The Captopril Prevention Project) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project randomised trial. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study III. Hypertension et sport . EUROPA : (European Trial On Reduction Of Cardiac Events With Perindopril In Stable Coronary Artery Disease) Fox KM. ACCELERATE : Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control: a randomised, parallel-group trial. Side effects: Common side effects of amlodipine and atorvastatin (Caduet) include dizziness or lightheadedness as your body adjusts to the medication. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lowerthan-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm: a multicentre randomised controlled trial.
ASCOT-BPLA : (The Anglo Scandinavian Cardiac Outcome Trial- Blood Pressure Lowering Arm). ASCOT-LLA : (The Anglo Scandinavian Cardiac Outcome Trial-Lipid Lowering Arm). Prevention of cardiovascular events with an antihyper-tensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm: a multicentre randomised controlled trial. CIBIS : (The Cardiac Insufficiency Bisoprolol Study) Willenheimer R et al. HOPE : (The Heart Outcomes Prevention Evaluation) The Heart Outcomes Prevention Evaluation Study Investigators. HOPE Design : The Heart Outcomes Prevention Evaluation Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. CHARM Investigators. Impact of candesartan on non-fatal myocardial infarction and cardiovascular death in patients with heart failure. IDACO Investigators. Tension artérielle élevée que faire . Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. DASH : Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet.
Souvent, la teneur en sodium de l’aliment y sera indiquée. 2001 Jan 4; 344(1):3-10. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Global, regional and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks: a systematic analysis for the Global Burden of Disease Study 1990-2015. Lancet. ACCOMPLISH, sous-analyse néphropathie : Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events : a prespecified secondary analysis of a randomised controlled trial.